Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients
NCT03004209Phase 4Withdrawn
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2016
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of erythropoietin in Autoimmune Encephalitis (AE), sponsored by Seoul National University Hospital. Planned start Dec 2016; status: withdrawn.
02
Drugs
erythropoietin
03
Conditions
Autoimmune Encephalitis (AE)
Beyond the preview
Go deeper on NCT03004209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004209.